Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1634801, 7 pages
https://doi.org/10.1155/2017/1634801
Review Article

“mTOR Signaling Pathway”: A Potential Target of Curcumin in the Treatment of Spinal Cord Injury

1Department of Histology and Embryology, Medical College, Shaoxing University, Zhejiang, China
2Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, China

Correspondence should be addressed to Xuehong Liu; moc.621@8856heuxuil

Received 5 December 2016; Revised 15 April 2017; Accepted 18 May 2017; Published 12 June 2017

Academic Editor: Ayhan Cömert

Copyright © 2017 Jingquan Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Singh, L. Tetreault, S. Kalsi-Ryan, A. Nouri, and M. G. Fehlings, “Global prevalence and incidence of traumatic spinal cord injury,” Clinical Epidemiology, vol. 6, pp. 309–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. A. Silva, N. Sousa, R. L. Reis, and A. J. Salgado, “From basics to clinical: a comprehensive review on spinal cord injury,” Progress in Neurobiology, vol. 114, pp. 25–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Berry, Z. Ahmed, P. Morgan-Warren, D. Fulton, and A. Logan, “Prospects for mTOR-mediated functional repair after central nervous system trauma,” Neurobiology of Disease, vol. 85, pp. 99–110, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Young, “Spinal cord regeneration,” Cell Transplantation, vol. 23, no. 4-5, pp. 573–611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kanno, H. Ozawa, A. Sekiguchi et al., “The role of mTOR signaling pathway in spinal cord injury,” Cell Cycle, vol. 11, no. 17, pp. 3175–3179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Mukhopadhyay, P. K. Panda, N. Sinha, D. N. Das, and S. K. Bhutia, “Autophagy and apoptosis: where do they meet?” Apoptosis, vol. 19, no. 4, pp. 555–566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H.-J. Wu, J.-L. Pu, P. R. Krafft, J.-M. Zhang, and S. Chen, “The Molecular Mechanisms Between Autophagy and Apoptosis: Potential Role in Central Nervous System Disorders,” Cellular and Molecular Neurobiology, vol. 35, no. 1, pp. 85–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Oral, Y. Akkoc, O. Bayraktar, and D. Gozuacik, “Physiological and pathological significance of the molecular cross-talk between autophagy and apoptosis,” Histology and Histopathology, vol. 31, no. 5, pp. 479–498, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Yao, L. Yang, J. Wang et al., “Neurological recovery and antioxidant effects of curcumin for spinal cord injury in the rat: a network meta-analysis and systematic review,” Journal of Neurotrauma, vol. 32, no. 6, pp. 381–391, 2015. View at Publisher · View at Google Scholar
  10. C. Cerella, A. Gaigneaux, M. Dicato, and M. Diederich, “Antagonistic role of natural compounds in mTOR-mediated metabolic reprogramming,” Cancer Letters, vol. 356, no. 2, pp. 251–262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Ahuja, S. Nori, L. Tetreault et al., “Traumatic Spinal Cord Injury—Repair and Regeneration,” Neurosurgery, vol. 80, pp. S9–S22, 2017. View at Publisher · View at Google Scholar
  12. H.-X. Yuan and K.-L. Guan, “Structural insights of mTOR complex 1,” Cell Research, vol. 26, no. 3, pp. 267-268, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. C. H. S. Aylett, E. Sauer, S. Imseng et al., “Architecture of human mTOR complex 1,” Science, vol. 351, no. 6268, pp. 48–52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Yang, D. G. Rudge, J. D. Koos, B. Vaidialingam, H. J. Yang, and N. P. Pavletich, “MTOR kinase structure, mechanism and regulation,” Nature, vol. 497, no. 7448, pp. 217–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Laplante and D. M. Sabatini, “MTOR signaling in growth control and disease,” Cell, vol. 149, no. 2, pp. 274–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Jaworski and M. Sheng, “The growing role of mTOR in neuronal development and plasticity,” Molecular Neurobiology, vol. 34, no. 3, pp. 205–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Switon, K. Kotulska, A. Janusz-Kaminska et al., “Molecular neurobiology of mTOR,” Neuroscience, vol. 341, pp. 112–153, 2017. View at Publisher · View at Google Scholar
  18. E. J. Bradbury, L. D. F. Moon, R. J. Popat et al., “Chondroitinase ABC promotes functional recovery after spinal cord injury,” Nature, vol. 416, no. 6881, pp. 636–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Wang, Z. Xiao, B. Chen et al., “Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway,” PLoS ONE, vol. 3, no. 3, Article ID e1856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Goldshmit, S. Kanner, M. Zacs et al., “Rapamycin increases neuronal survival, reduces inflammation and astrocyte proliferation after spinal cord injury,” Molecular and Cellular Neuroscience, vol. 68, pp. 82–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-H. Chen, C.-S. Sung, S.-Y. Huang et al., “The role of the PI3K/Akt/mTOR pathway in glial scar formation following spinal cord injury,” Experimental Neurology, vol. 278, pp. 27–41, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Jahan and S. S. Hannila, “Transforming growth factor β-induced expression of chondroitin sulfate proteoglycans is mediated through non-Smad signaling pathways,” Experimental Neurology, vol. 263, pp. 372–384, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Codeluppi, C. I. Svensson, M. P. Hefferan et al., “The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord,” Journal of Neuroscience, vol. 29, no. 4, pp. 1093–1104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Wu, M. C. Klaw, T. Connors, N. Kholodilov, R. E. Burke, and V. J. Tom, “Expressing constitutively active rheb in adult neurons after a complete spinal cord injury enhances axonal regeneration beyond a chondroitinase-treated glial scar,” The Journal of Neuroscience, vol. 35, no. 31, pp. 11068–11080, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Lu, Y. Wang, L. Graham et al., “Long-distance growth and connectivity of neural stem cells after severe spinal cord injury,” Cell, vol. 150, no. 6, pp. 1264–1273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Liu, Y. Lu, J. K. Lee et al., “PTEN deletion enhances the regenerative ability of adult corticospinal neurons,” Nature Neuroscience, vol. 13, no. 9, pp. 1075–1081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Jin, Y. Liu, F. Sun, X. Wang, X. Liu, and Z. He, “Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3,” Nature Communications, vol. 6, article 8074, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Zukor, S. Belin, C. Wang, N. Keelan, X. Wang, and Z. He, “Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury,” The Journal of Neuroscience, vol. 33, no. 39, pp. 15350–15361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Lewandowski and O. Steward, “AAVshRNA-mediated suppression of PTEN in adult rats in combination with salmon fibrin administration enables regenerative growth of corticospinal axons and enhances recovery of voluntary motor function after cervical spinal cord injury,” Journal of Neuroscience, vol. 34, no. 30, pp. 9951–9962, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. A. Danilov and O. Steward, “Conditional genetic deletion of PTEN after a spinal cord injury enhances regenerative growth of CST axons and motor function recovery in mice,” Experimental Neurology, vol. 266, pp. 147–160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. C. L. Walker and X.-M. Xu, “PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury,” Neuroscience Letters, vol. 573, pp. 64–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Ohtake, D. Park, P. M. Abdul-Muneer et al., “The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury,” Biomaterials, vol. 35, no. 16, pp. 4610–4626, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Du, S. Zheng, Q. Zhang et al., “Pten deletion promotes regrowth of corticospinal tract axons 1 year after spinal cord injury,” Journal of Neuroscience, vol. 35, no. 26, pp. 9754–9763, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. E. A. Gutilla, M. M. Buyukozturk, and O. Steward, “Long-term consequences of conditional genetic deletion of PTEN in the sensorimotor cortex of neonatal mice,” Experimental Neurology, vol. 279, pp. 27–39, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. C. G. Geoffroy, B. J. Hilton, W. Tetzlaff, and B. Zheng, “Evidence for an Age-Dependent Decline in Axon Regeneration in the Adult Mammalian Central Nervous System,” Cell Reports, vol. 15, no. 2, pp. 238–246, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Y. Hu, Z. G. Sun, Y. M. Wen et al., “ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats,” Neuroscience, vol. 169, no. 3, pp. 1046–1062, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Yang, H. Wen, S. Ou, J. Cui, and D. Fan, “IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation,” Experimental Neurology, vol. 236, no. 1, pp. 19–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Yang, Y. Qin, C. Bian, Y. Zhao, and W. Zhang, “Intrathecal delivery of IL-6 reactivates the intrinsic growth capacity of pyramidal cells in the sensorimotor cortex after spinal cord injury,” PLoS ONE, vol. 10, no. 5, Article ID e0127772, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Liu, M. R. Detloff, K. N. Miller, L. Santi, and J. D. Houlé, “Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury,” Experimental Neurology, vol. 233, no. 1, pp. 447–456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. V. Gutierrez, M. Clark, O. Nwanna, and W. J. Alilain, “Intermittent hypoxia training after C2 hemisection modifies the expression of PTEN and mTOR,” Experimental Neurology, vol. 248, pp. 45–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Sekiguchi, H. Kanno, H. Ozawa, S. Yamaya, and E. Itoi, “Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice,” Journal of Neurotrauma, vol. 29, no. 5, pp. 946–956, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Gao, G. Wang, Y. Wang et al., “Neuroprotective Effect of Simvastatin via Inducing the Autophagy on Spinal Cord Injury in the Rat Model,” BioMed Research International, vol. 2015, Article ID 260161, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Zhang and J. Ren, “Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management,” Pharmacology and Therapeutics, vol. 161, pp. 52–66, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Zhang, X. Xu, and J. Ren, “MTOR overactivation and interrupted autophagy flux in obese hearts: A dicey assembly?” Autophagy, vol. 9, no. 6, pp. 939–941, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Wang and J. Ren, “mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: Role of p38 MAPK and Foxo1,” Pharmacological Research, vol. 111, pp. 357–373, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. H.-Y. Zhang, Z.-G. Wang, F.-Z. Wu et al., “Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protection in a rat model of spinal cord injury,” Molecular Neurobiology, vol. 48, no. 3, pp. 452–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. C. L. Walker, M. J. Walker, N.-K. Liu et al., “Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury,” PLoS ONE, vol. 7, no. 1, Article ID e30012, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. Z.-Y. Wang, J.-H. Lin, A. Muharram, and W.-G. Liu, “Beclin-1-mediated autophagy protects spinal cord neurons against mechanical injury-induced apoptosis,” Apoptosis, vol. 19, no. 6, pp. 933–945, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Zhang, P. Tang, H. Hou et al., “Autophagy reduces neuronal damage and promotes locomotor recovery via inhibition of apoptosis after spinal cord injury in rats,” Molecular Neurobiology, vol. 49, no. 1, pp. 276–287, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. K.-L. Zhou, Y.-F. Zhou, K. Wu et al., “Stimulation of autophagy promotes functional recovery in diabetic rats with spinal cord injury,” Scientific Reports, vol. 5, Article ID 17130, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Guo, S. Liu, X. Zhang et al., “G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice,” Laboratory Investigation, vol. 95, no. 12, pp. 1439–1449, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Schraufstätter and H. Bernt, “Antibacterial action of curcumin and related compounds,” Nature, vol. 164, no. 4167, pp. 456-457, 1949. View at Publisher · View at Google Scholar · View at Scopus
  53. P. A. Subramani, K. Panati, and V. R. Narala, “Curcumin Nanotechnologies and Its Anticancer Activity,” Nutrition and Cancer, vol. 69, no. 3, pp. 381–393, 2017. View at Publisher · View at Google Scholar
  54. B. Liang, Z. Liu, Y. Cao et al., “MC37, a new mono-carbonyl curcumin analog, induces G2/M cell cycle arrest and mitochondria-mediated apoptosis in human colorectal cancer cells,” European Journal of Pharmacology, vol. 796, pp. 139–148, 2017. View at Publisher · View at Google Scholar
  55. S. Bisht, M. Schlesinger, A. Rupp et al., “A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: Towards future combination therapies,” Journal of Nanobiotechnology, vol. 14, no. 1, article no. 57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. A. S. Jiménez-Osorio, A. Monroy, and S. Alavez, “Curcumin and insulin resistance—Molecular targets and clinical evidences,” BioFactors, vol. 42, no. 6, pp. 561–580, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Rivera-Mancía, M. C. Lozada-García, and J. Pedraza-Chaverri, “Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications,” European Journal of Pharmacology, vol. 756, pp. 30–37, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Ren and J. R. Sowers, “Application of a novel curcumin analog in the management of diabetic cardiomyopathy,” Diabetes, vol. 63, no. 10, pp. 3166–3168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Pan, Y. Wang, Y. Zhao et al., “Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy,” Diabetes, vol. 63, no. 10, pp. 3497–3511, 2014. View at Publisher · View at Google Scholar
  60. Y. Wang, S. Zhou, W. Sun et al., “Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression,” American Journal of Physiology - Endocrinology and Metabolism, vol. 306, no. 11, pp. E1239–E1247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Wu, L. Kong, Y. Tan et al., “C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21,” Diabetologia, vol. 59, no. 7, pp. 1558–1568, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Wang, Y. Wang, M. Luo et al., “Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1852, no. 1, pp. 34–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Pan, Y. Huang, Z. Wang et al., “Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy,” Journal of Cellular and Molecular Medicine, vol. 18, no. 2, pp. 231–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Jiang, J. Han, T. Li et al., “Curcumin as a potential protective compound against cardiac diseases,” Pharmacological Research, vol. 119, pp. 373–383, 2017. View at Publisher · View at Google Scholar
  65. F. Ullah, A. Liang, A. Rangel et al., “High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation,” Archives of Toxicology, vol. 91, no. 4, pp. 1623–1634, 2017. View at Publisher · View at Google Scholar
  66. S. C. Gupta, S. Patchva, and B. B. Aggarwal, “Therapeutic roles of curcumin: lessons learned from clinical trials,” AAPS Journal, vol. 15, no. 1, pp. 195–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Pulido-Moran, J. Moreno-Fernandez, C. Ramirez-Tortosa, and M. Ramirez-Tortosa, “Curcumin and health,” Molecules, vol. 21, no. 3, article E264, 2016. View at Publisher · View at Google Scholar
  68. G. Kumar, S. Mittal, K. Sak, and H. S. Tuli, “Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives,” Life Sciences, vol. 148, pp. 313–328, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Wang, J. Zhang, C.-J. Zhang et al., “In situ Proteomic Profiling of Curcumin Targets in HCT116 Colon Cancer Cell Line,” Scientific Reports, vol. 6, Article ID 22146, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. C. S. Beevers, L. Chen, L. Liu, Y. Luo, N. J. G. Webster, and S. Huang, “Curcumin disrupts the mammalian target of rapamycin-raptor complex,” Cancer Research, vol. 69, no. 3, pp. 1000–1008, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Yuan, M. Zou, X. Xiang et al., “Curcumin improves neural function after spinal cord injury by the joint inhibition of the intracellular and extracellular components of glial scar,” Journal of Surgical Research, vol. 195, no. 1, pp. 235–245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. Y.-F. Wang, J.-N. Zu, J. Li, C. Chen, C.-Y. Xi, and J.-L. Yan, “Curcumin promotes the spinal cord repair via inhibition of glial scar formation and inflammation,” Neuroscience Letters, vol. 560, pp. 51–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. L. M. Urdzikova, K. Karova, J. Ruzicka et al., “The anti-inflammatory compound curcumin enhances locomotor and sensory recovery after spinal cord injury in rats by immunomodulation,” International Journal of Molecular Sciences, vol. 17, no. 1, article no. 49, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. C.-C. Lin, T.-H. Chiang, W.-J. Chen, Y.-Y. Sun, Y.-H. Lee, and M.-S. Lin, “CISD2 serves a novel role as a suppressor of nitric oxide signalling and curcumin increases CISD2 expression in spinal cord injuries,” Injury, vol. 46, no. 12, pp. 2341–2350, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Ni, W. Jin, T. Zhu et al., “Curcumin modulates TLR4/NF-κB inflammatory signaling pathway following traumatic spinal cord injury in rats,” Journal of Spinal Cord Medicine, vol. 38, no. 2, pp. 199–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Ni, W. Jin, B. Yuan et al., “Curcumin inhibits the increase of labile zinc and the expression of inflammatory cytokines after traumatic spinal cord injury in rats,” Journal of Surgical Research, vol. 187, no. 2, pp. 646–652, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. W. Jin, J. Wang, T. Zhu et al., “Anti-inflammatory effects of curcumin in experimental spinal cord injury in rats,” Inflammation Research, vol. 63, no. 5, pp. 381–387, 2014. View at Publisher · View at Google Scholar · View at Scopus